Skip to main content

Acadia Pharmaceuticals Shares Plunged Yesterday After A CNN Report

Shares of Acadia Pharmaceuticals Inc. fell by more than 25% on Monday after an article published on the CNN website raised concerns on the company’s lead drug, Nuplazid.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.